Bank of America’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729 | Sell |
|
|||||
|
2025
Q1 | $43.6K | Buy |
|
|||||
|
2024
Q4 | $9.52K | Sell |
|
|||||
|
2024
Q3 | $19.5K | Buy |
|
|||||
|
2024
Q2 | $16.1K | Sell |
|
|||||
|
2024
Q1 | $34.2K | Sell |
|
|||||
|
2023
Q4 | $47.6K | Buy |
|
|||||
|
2023
Q3 | $93.7K | Buy |
|
|||||
|
2023
Q2 | $93K | Sell |
|
|||||
|
2023
Q1 | $110K | Sell |
|
|||||
|
2022
Q4 | $154K | Buy |
|
|||||
|
2022
Q3 | $111K | Sell |
|
|||||
|
2022
Q2 | $81K | Sell |
|
|||||
|
2022
Q1 | $158K | Sell |
|
|||||
|
2021
Q4 | $1.43M | Buy |
|
|||||
|
2021
Q3 | $355K | Sell |
|
|||||
|
2021
Q2 | $325K | Sell |
|
|||||
|
2021
Q1 | $738K | Buy |
|
|||||
|
2020
Q4 | $108K | Buy |
|
|||||
|
2020
Q3 | $27K | Buy |
|